Cheaper Alternatives to Cora Health: GLP-1 Providers Compared

Last reviewed: September 16, 2026 Last updated: September 16, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance. His work has included scaling healthcare startups, leading CLIA lab integrations, and helping expand consumer access to precision health tools.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

PlexusDx publishes this comparison and is one of the providers discussed. We use the same evidence rules for our own program and competing programs.

The short answer

Cora Health delivers the lowest advertised per-month rate in this field when you prepay twelve months upfront: $99 per month equivalent for semaglutide ($1,188 upfront) and $135 per month equivalent for tirzepatide ($1,620 upfront), captured September 4, 2026. That annual-prepaid rate beats every competitor in this analysis by $50 to $90 per month for semaglutide and by $114 to $224 per month for tirzepatide. But the calculation shifts when you compare month-to-month flexibility or shorter prepay windows. Cora's month-to-month semaglutide rate ($175) is $14 per month less than PlexusDx ($189), while PlexusDx's six-month semaglutide plan ($149 per month, $894 every six months) sits between Cora's semiannual ($120 per month equivalent, $720 prepaid) and quarterly ($145 per month equivalent, $435 prepaid) tiers. For tirzepatide, Cora's month-to-month rate ($225) is $64 per month less than PlexusDx ($289), and Cora's semiannual tirzepatide rate ($175 per month equivalent, $1,050 prepaid every six months) undercuts PlexusDx's six-month plan ($249 per month, $1,494 every six months) by $74 per month. If you can commit capital upfront and Cora's fulfillment model fits your situation, the annual plan is the lowest published list price we found. If you need month-to-month flexibility or want to test a provider before locking in, the alternatives narrow and the trade-offs become more nuanced.

At-a-glance comparison

Cora Health pricing captured September 4, 2026 from trycora.io/plans; competitor pricing captured July 17–23, 2026 via provider checkout flows. All figures are published list prices; promotional or referral offers not included.

Full pricing breakdown: commitment tiers and twelve-month cost

Cora Health publishes four billing tiers for each medication. We compare those tiers to PlexusDx's three billing options (month-to-month, three-month, six-month) and calculate the total outlay over twelve months for each path. Every prepaid per-month equivalent below is our calculation, derived from the documented upfront price and term length.

Semaglutide injection: like-for-like

Tirzepatide injection: like-for-like

Cora Health pricing captured September 4, 2026 from trycora.io/plans. PlexusDx pricing captured September 16, 2026. Per-month equivalents for prepaid plans are our calculation. Cora's published page notes flat pricing by dose; confirm whether the annual supply ships at once or in installments before committing.

How the broader field compares

Beyond the Cora–PlexusDx head-to-head, six additional providers appear in checkout-verified pricing captured between July 17 and July 23, 2026. The patterns:

• Eden advertises $99 per month for semaglutide medication, but the program requires a separate $99 per month membership, bringing the all-in cost to $198 per month for semaglutide and $298 per month for tirzepatide. No prepay tier was documented at capture.
• Embody publishes $299 per month for semaglutide and $349 per month for tirzepatide with no membership fee and same-price-at-every-dose simplicity. No prepay tier was documented.
• Found lists $289 per month for semaglutide and $359 per month for tirzepatide on its cash-pay month-to-month plan, medication included. No separate membership line item appears in that rate.
• Henry Meds offers semaglutide injection at $297 per month; tirzepatide is available only as an oral dissolving tablet, and no monthly injection rate was captured.
• Peak Wellness publishes $249 per month for semaglutide and $349 per month for tirzepatide as ongoing monthly rates, with a documented lower per-month rate on six-month prepaid plans (specific rate not captured at the time).
• TrimRx advertises $199 semaglutide and $349 tirzepatide but checkout flows captured $299 and $399 as the ongoing monthly rates; the provider offers three-month, six-month, and twelve-month prepaid tiers that reduce the per-month cost, but those tier rates were not captured in the July evidence window.

When you line up month-to-month rates with no prepay requirement, Cora Health's $175 semaglutide and $225 tirzepatide sit at the low end of the range, with only PlexusDx ($189 sema, $289 tirz) and Eden's all-in $198/$298 coming within $50 per month. The rest cluster between $249 and $359 per month depending on medication.

Decision factors beyond the monthly rate

Capital commitment and liquidity

Cora Health's annual plan requires $1,188 upfront for semaglutide or $1,620 for tirzepatide. That capital outlay buys the lowest per-month equivalent in this analysis, but it also locks your spending for twelve months. If your dose changes, if you experience side effects that require a pause, or if your clinical situation shifts, you carry the economic exposure of a prepaid year. PlexusDx's six-month plan ($894 semaglutide, $1,494 tirzepatide every six months) halves the commitment window; the three-month option ($507 semaglutide, $807 tirzepatide per quarter) quarters it. Month-to-month billing preserves maximum flexibility but trades that flexibility for a higher per-month rate at every provider that offers both models.

Dose titration and same-price policies

Both Cora Health and PlexusDx publish flat pricing across all doses. If you start at a lower dose and titrate upward over months two through four—common in clinical GLP-1 protocols—you pay the same monthly rate at 0.25 mg as you do at 2.4 mg semaglutide or 15 mg tirzepatide. Providers that tier pricing by dose can create a lower entry cost in month one but a higher cost once you reach therapeutic levels. The flat-rate model makes year-one budgeting straightforward.

Service reliability and fulfillment consistency

PlexusDx holds a 4.3-star rating on Trustpilot, with 79 percent of reviews at five stars and 83 percent at four stars or higher, captured September 9, 2026. Cora Health maintains a Trustpilot profile at trustpilot.com/review/trycora.io, captured September 4, 2026, but no rating or review volume was recorded in the research window. The absence of rating data does not imply poor service—it may reflect a newer market presence or lower review velocity—but it leaves a gap in the third-party service record. When you prepay twelve months, fulfillment consistency, customer-support responsiveness, and the provider's ability to navigate shortages or regulatory shifts become material. A month-to-month arrangement limits your exposure to any single provider's operational disruptions.

Membership unbundling

Cora Health, PlexusDx, Embody, Found, Henry Meds, Peak Wellness, and TrimRx all publish flat monthly rates with no separate membership fee; consultation, medication, shipping, and monitoring are bundled into the single line item. Eden splits medication ($99/month) from membership ($99/month), which can create flexibility if you source medication elsewhere and want only the coaching or tracking layer—but if you need both, the all-in cost is higher than Cora's or PlexusDx's bundled rates.

Choose Cora Health if…

• You have $1,188 (semaglutide) or $1,620 (tirzepatide) liquid capital and want to lock the lowest advertised per-month rate in this comparison.
• You are confident in twelve-month commitment and do not anticipate needing to pause, switch medications, or change providers within that window.
• Your clinical history and current health status make dose titration predictable, and you expect to reach and maintain a therapeutic dose without interruption.
• You value the published price floor over the presence of a large third-party review base or an established service track record visible in rating platforms.

Choose PlexusDx if…

• You want the cost discipline of a multi-month plan but prefer six-month ($894 semaglutide, $1,494 tirzepatide) or three-month ($507 semaglutide, $807 tirzepatide) capital windows over a full-year prepay.
• You are starting GLP-1 therapy for the first time and want the flexibility to reassess after one or two quarters without the financial exposure of a twelve-month lock.
• You value the transparency of a 4.3-star Trustpilot rating and the signal that 83 percent of reviews sit at four stars or higher, captured from a verified public profile.
• You want straightforward semaglutide injection at $189 month-to-month or tirzepatide injection at $289 month-to-month with no prepay requirement, knowing you pay $14 to $64 more per month than Cora's month-to-month rate but retain the ability to cancel or pause at any billing cycle.

Choose Embody, Peak Wellness, or Found if…

• You want month-to-month simplicity and are willing to pay $249–$359 per month (depending on provider and medication) in exchange for no prepay commitment and a fully bundled service model.
• Your budget accommodates a higher monthly outlay but you prioritize liquidity and the ability to switch or pause without forfeiting prepaid capital.
• You prefer a provider that has published ongoing rates without advertised promotional pricing or prepay structures, signaling stable long-term list pricing.

When Eden or Henry Meds may fit

Eden's split billing—$99 medication, $99 membership—can make sense if you already have medication access through another channel (insurance, separate compounding relationship, or a dose-reduction strategy) and want only the tracking, coaching, and monitoring layer. For individuals who need both medication and support, the $198/$298 all-in cost sits in the middle of the month-to-month range, below Embody and Found but above Cora and PlexusDx. Henry Meds offers competitive semaglutide pricing at $297 per month, but if you are considering tirzepatide injection, the lack of a published monthly injection rate narrows its relevance to this comparison.

Methodology and freshness

We captured Cora Health pricing on September 4, 2026, directly from trycora.io/plans. PlexusDx pricing was captured September 16, 2026, from live product pages. Competitor pricing (Eden, Embody, Found, Henry Meds, Peak Wellness, TrimRx) was captured between July 17 and July 23, 2026, via provider checkout flows. All per-month equivalents for prepaid plans are our calculation, derived from the documented upfront price divided by the number of months in the commitment term. Twelve-month totals are our calculation, multiplying the per-month rate (published or calculated) by twelve or summing the documented prepayment cycles over one year. PlexusDx's Trustpilot rating (4.3 stars, 79 percent five-star, 83 percent four-star-or-higher) was verified September 9, 2026, at trustpilot.com/review/plexusdx.com. Cora Health's Trustpilot profile existence was confirmed September 4, 2026, at trustpilot.com/review/trycora.io; no rating or review count was available at capture. We include only prices observed or published by the provider; we do not apply promotional or referral credits unless explicitly captured and labeled. Pricing may change; confirm current rates at provider checkout before committing capital.

Frequently Asked Questions

Does Cora Health ship the full twelve-month supply upfront when you prepay the annual plan?

The pricing page captured September 4, 2026, does not specify whether the annual supply ships at once or in monthly installments. We recommend confirming the fulfillment schedule directly with Cora Health before prepaying $1,188 or $1,620, especially if you need to understand refrigeration requirements, travel logistics, or your ability to pause if clinical circumstances change mid-year.

Can I switch from month-to-month to a prepaid plan mid-program?

Neither Cora Health nor PlexusDx published a documented policy on mid-program billing-tier changes in the captured evidence. If you start month-to-month and later want to lock a lower per-month rate by prepaying three, six, or twelve months, contact the provider's support team to confirm whether that transition is allowed and whether any retroactive credit applies to months already billed.

Are compounded semaglutide and tirzepatide FDA-approved?

No. Compounded medications are not FDA-approved. The FDA does not review compounded drugs before marketing for safety, effectiveness, or quality. A licensed clinician determines whether a prescription is appropriate for an individual patient. PlexusDx works with licensed 503A compounding pharmacies. Every provider in this comparison that offers compounded GLP-1 medications operates under the same regulatory framework.

What happens if I prepay six or twelve months and need to stop treatment early?

Refund and cancellation policies vary by provider and were not uniformly captured in the September 4, 2026, pricing evidence. Before committing to any multi-month prepaid plan, request the provider's written cancellation, pause, and refund policy. Understand whether unused months are refundable, whether you can pause and resume later, and what documentation (clinician note, adverse-event report) may be required to trigger a refund or credit.

How do I know if the lower price is worth the longer commitment?

Calculate the absolute dollar difference over twelve months (shown in the tables above), then divide that savings by the number of months of additional commitment. For example, Cora's twelve-month semaglutide plan saves you $600 over twelve months compared to PlexusDx's six-month plan, or $50 per month. If your clinical situation is stable, your dose predictable, and your liquidity sufficient to absorb $1,188 upfront, that $600 annual savings may justify the lock. If you are new to GLP-1 therapy, titrating dose, or uncertain about tolerability, the flexibility of a shorter commitment window may be worth paying $50 more per month to preserve your ability to pause, switch, or stop without forfeiting prepaid capital.

Sources

• PlexusDx product pages (plexusdx.com/products/semaglutide-injection, plexusdx.com/products/tirzepatide-injection), accessed September 16, 2026
• Cora Health pricing page (trycora.io/plans), accessed September 4, 2026
• Cora Health Trustpilot profile (trustpilot.com/review/trycora.io), accessed September 4, 2026
• PlexusDx Trustpilot profile (trustpilot.com/review/plexusdx.com), accessed September 9, 2026
• Provider checkout flows for Eden, Embody, Found, Henry Meds, Peak Wellness, and TrimRx, accessed July 17–23, 2026
• Reddit comparison discussion (reddit.com/r/TirzepatideRX/comments/1thrzbp/comparing_glp1_telehealth_providers_does_paying/), accessed September 4, 2026

Compounded medication disclosure: Compounded medications are not FDA-approved. The FDA does not review compounded drugs before marketing for safety, effectiveness, or quality. A licensed clinician determines whether a prescription is appropriate for an individual patient. PlexusDx works with licensed 503A compounding pharmacies.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance. References are included at the end of the article when scientific, medical, or health-related claims are discussed.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.